Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm.
Caturano A, Nilo D, Lorenzo GD, Rocco M, Tagliaferri G, Piacevole A, Donnarumma M, Iadicicco I, Moretto SM, Acierno C, Sardu C, Russo V, Perrone MA, Vetrano E, Galiero R, Marfella R, Bonfrate L, Rinaldi L, Conte C, Sasso FC. Caturano A, et al. Among authors: sardu c. Rev Cardiovasc Med. 2025 Nov 27;26(11):43143. doi: 10.31083/RCM43143. eCollection 2025 Nov. Rev Cardiovasc Med. 2025. PMID: 41356318 Free PMC article. Review.
Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: Post-hoc analysis of the nephropathy in diabetes type 2 trial.
Caturano A, Simeon V, Galiero R, Russo V, De Nicola L, Chiodini P, Rinaldi L, Vetrano E, Salvatore T, Conte C, Acierno C, Sardu C, Marfella R, Minutolo R, Sasso FC. Caturano A, et al. Among authors: sardu c. World J Diabetes. 2025 Nov 15;16(11):111698. doi: 10.4239/wjd.v16.i11.111698. World J Diabetes. 2025. PMID: 41278446 Free PMC article. Clinical Trial.
Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use.
Marfella R, Marfella LV, Fumagalli C, Rinaldi L, Sasso FC, Cozzolino D, Nappo F, Sellitto A, Romano C, Carusone C, Diodato G, Russo P, Marfella L, Tarantino NM, Carpinella G, Furbatto F, Gentile S, Guarino G, Satta E, Bellis A, Marinelli L, Donisi I, D'Onofrio N, Mauro C, Cappabianca S, Balestrieri ML, Sardu C. Marfella R, et al. Among authors: sardu c. Eur Heart J Imaging Methods Pract. 2025 Oct 23;3(4):qyaf129. doi: 10.1093/ehjimp/qyaf129. eCollection 2025 Oct. Eur Heart J Imaging Methods Pract. 2025. PMID: 41268052 Free PMC article.
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.
Sardu C, Marfella LV, Fumagalli C, Rinaldi L, Sasso FC, Cozzolino D, Nappo F, Sellitto A, Romano C, Carusone C, Russo P, Marfella L, Tarantino NM, Carpinella G, Furbatto F, Gentile S, Guarino G, Satta E, Bellis A, Marinelli L, Donisi I, D'Onofrio N, Mauro C, Cappabianca S, Balestrieri ML, Marfella R. Sardu C, et al. Int J Mol Sci. 2025 Oct 14;26(20):9977. doi: 10.3390/ijms26209977. Int J Mol Sci. 2025. PMID: 41155271 Free PMC article.
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study.
Caturano A, Galiero R, Simeon V, Acierno C, Nilo D, Marrone A, Trotta MC, Vetrano E, Sardu C, Russo V, Conte C, D'Onofrio N, Chiodini P, Marfella R, Balestrieri ML, D'Amico M, Rinaldi L, Sasso FC. Caturano A, et al. Among authors: sardu c. Nutr Metab Cardiovasc Dis. 2025 Aug 23:104284. doi: 10.1016/j.numecd.2025.104284. Online ahead of print. Nutr Metab Cardiovasc Dis. 2025. PMID: 40935714
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study.
Sardu C, Marfella LV, Rinaldi L, Sasso FC, Cozzolino D, Nappo F, Sellitto A, Romano C, Carusone C, D'Onofrio N, Trotta MC, Riccio J, Cioffi D, Volpicelli M, Marca C, Marrazzo N, Giordano V, Fumagalli C, Landolfi A, Abitabile M, Marfella L, Balestrieri ML, Marfella R. Sardu C, et al. Diabetes Res Clin Pract. 2025 Oct;228:112452. doi: 10.1016/j.diabres.2025.112452. Epub 2025 Sep 3. Diabetes Res Clin Pract. 2025. PMID: 40912462 Free article.
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study.
Vetrano E, Galiero R, Simeon V, Palmiero G, Cesaro A, Caturano A, Rinaldi L, Salvatore T, Ruggiero R, Di Palo MR, Sardu C, Marfella R, Calabrò P, Sasso FC. Vetrano E, et al. Among authors: sardu c. Pharmaceuticals (Basel). 2025 Aug 14;18(8):1200. doi: 10.3390/ph18081200. Pharmaceuticals (Basel). 2025. PMID: 40872591 Free PMC article.
259 results